Nordic Life Science 1
P R E D I C T I N G 2 0 2 5 A N D B E Y O N D INV
ESTMENT OUTLOOK O1 O2 O3 O4 01. MALA VALROY “We’re seeing many unique approaches in the world of molecular tools,” says Mala Valroy, Investment Manager, Industrifonden. READ MORE ON PAGE 58 02. MILLA KOISTINAHO “One of this year’s significant market trends is the resurgence of larger financing rounds,” says Milla Koistinaho, Partner, Innovestor. READ MORE ON PAGE 62 03. SUSANNA FRANCKE RODAU “We see growing interest in technologies that support value-based care," says Susanna Francke Rodau, CEO, Segulah Medical Acceleration. READ MORE ON PAGE 64 04. FARZAD ABDI-DEZFULI “The EU is looking at greater self-sufficiency and regulatory unity,” notes Farzad AbdiDezfuli, Partner, Sarsia Management. READ MORE ON PAGE 66 05. TED FJÄLLMAN & TIM OPLER Ted Fjällman, CEO, Flerie, and Tim Opler Managing Director, Stifel, share their thoughts on the current financial landscape. READ MORE ON PAGE 70 05 NORDICLIFESCIENCE.ORG | 57 PHOTO KARL GABOR PHOTO THOR BRODRESKIFT